1. Carmen A. Puliafito

    0 Comments Leave a Comment

    1-15 of 68 1 2 3 4 5 »
    1. Mentioned In 68 Articles

    2. Further advances in optical coherence tomography 2012

      Further advances in optical coherence tomography 2012

      This fourth annual supplement to Ophthalmic Surgery, Lasers & Imaging devoted to optical coherence tomography (OCT) is a testament to the unique status and evolution of perhaps the single most important development of the era in ophthalmic imaging. Presented here are the latest reports of diagnosis and treatment challenges utilizing OCT to study and solve the problem and benefit the patient. They describe the most recent technological innovations and applications of the technique first described in 1991 in the journal Science , 1 and as a group represent the broad range of relevance of this imaging technique. Original clinical and experimental studies ...

      Read Full Article
    3. OHSU Casey Eye Institute Inventor Dr. David Huang Earns International Award for Advances in Eye Imaging

      OHSU Casey Eye Institute Inventor Dr. David Huang Earns International Award for Advances in Eye Imaging
      ... OCT in glaucoma and anterior eye surgery. The 2012 Champalimaud Vision Award is shared by: Fujimoto; Huang; Carmen Puliafito, M.D., M.B.A., dean and professor of ophthalmology, Keck School of Medicine, University of So...
      Read Full Article
    4. MIT Researchers Dr. James Fujimoto and Mr. Eric Swanson Awarded the 2012 António Champalimaud Vision Award

      MIT Researchers Dr. James Fujimoto and Mr. Eric Swanson Awarded the 2012 António Champalimaud Vision Award
      ...dous promise for the future that rate may increase substantially.Fujimoto’s collaborators and co-honorees are Carmen A. Puliafito, MD, dean and professor of ophthalmology at the Keck School of Medicine at USC; David Huan...
      Read Full Article
    5. Finding “Big Ideas” in Ophthalmic Innovation - Venture Capitalists Will Back Potential “Game Changers”

      Finding “Big Ideas” in Ophthalmic Innovation - Venture Capitalists Will Back Potential “Game Changers”
      ...first OCT company called Advanced Ophthalmic Devices (AOD) was founded by myself, Dr. James Fujimoto, and Dr. Carmen Puliafito. AOD was acquired in 1994 by Zeiss and formed the basis of Zeiss's highly successful OCT prod...
      Read Full Article
    6. Visible light optical coherence tomography for in vivo imaging the spectral contrasts of the retinal nerve fiber layer

      Visible light optical coherence tomography for in vivo imaging the spectral contrasts of the retinal nerve fiber layer

      The ultimate goal of the study is to provide an imaging tool to detect the earliest signs of glaucoma before clinically visible damage occurs to the retinal nerve fiber layer (RNFL). Studies have shown that the optical reflectance of the damaged RNFL at short wavelength ( reduced much more than that at long wavelength, which provides spectral contrasts for imaging the earliest damage to the RNFL. To image the spectral contrasts we built a dual-band spectral-domain optical coherence tomography (SD-OCT) with centered wavelength of 415nm (VIS) and 808nm (NIR), respectively. The light at the two bands was provided by the fundamental ...

      Read Full Article
    7. Dual-band spectral-domain optical coherence tomography for in vivo imaging the spectral contrasts of the retinal nerve fiber layer

      Dual-band spectral-domain optical coherence tomography for in vivo imaging the spectral contrasts of the retinal nerve fiber layer
      ...ne ToC Category: Category Pending Citation Xiangyang Zhang, Jianming Hu, Robert W. Knighton, Xiang-Run Huang, Carmen A. Puliafito, and Shuliang Jiao, "Dual-band spectral-domain optical coherence tomography for in vivo im...
      Read Full Article
    8. Photoacoustic Ophthalmoscopy for In Vivo Retinal Imaging: Current Status and Prospects

      Photoacoustic Ophthalmoscopy for In Vivo Retinal Imaging: Current Status and Prospects

      Photoacoustic ophthalmoscopy (PAOM) is a new retinal imaging technology that offers the unique capability to measure optical absorption in the retina. Because PAOM is compatible with optical coherence tomography, scanning laser ophthalmoscopy, and autofluorescence imaging, registered multimodal images can be acquired from a single device at comparable resolution for comprehensive anatomic and functional retinal characterizations. Therefore, PAOM is anticipated to have applications in both research and clinical diagnosis of many blinding diseases. The authors explain the basic principles of the photoacoustic effect and imaging. Then, different types of photoacoustic microscopy are introduced and compared. Finally, the current status of photoacoustic ...

      Read Full Article
    9. 1-15 of 68 1 2 3 4 5 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Doppler, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Carmen A. Puliafito

    Carmen A. Puliafito

    Dr. Carmen A. Puliafito was appointed dean and holder of the May S. and John Hooval Dean’s Chair at the Keck School of Medicine of USC effective November 1, 2007. He also serves as a professor of ophthalmology and health management.  Before joining USC, Puliafito was chair of the Department of Ophthalmology and director of the Bascom Palmer Eye Institute at the University of Miami’s Miller School of Medicine. There, he oversaw a twofold increase in faculty size, a rise from 34th to 14th in National Institutes of Health funding within a three-year span, and the reclaiming of the top position in U.S. News & World Report’s eye-hospital rankings from the Wilmer Eye Institute at Johns Hopkins University. He also guided fundraising and the development of a $22 million, seven-acre, state-of-the-art campus in Palm Beach Gardens.  Puliafito earned his medical degree, magna cum laude, at Harvard Medical School. Following a residency and fellowships at the Massachusetts Eye and Ear Infirmary (MEEI), he served on the faculties of both Harvard and MIT and founded MEEI’s Morse Laser Center and Laboratory. He went on to build an eye program at Tufts University, where he became founding director of the New England Eye Center.  An internationally recognized leader in ophthalmic laser technology, Puliafito has served as president of the American Society for Laser Medicine and Surgery and as trustee and president of the Association for Research in Vision and Ophthalmology, the world’s largest eye-research organization. He holds two U.S. patents and has written more than 120 peer-reviewed scientific articles as well as six books.   In addition to his MD from Harvard University, Puliafito has an MBA from the Wharton School of the University of Pennsylvania.

  3. Quotes

    1. OCT has revolutionized the treatment of eye disease on a global basis, and it is now routinely used to make clinical decisions about treating patients with blinding diseases such as macular degeneration, diabetic retinopathy and glaucoma.
      In Cirrus HD-OCT Record Number of 10,000 Installations and Prestigious Award for OCT Inventors
    2. OCT is a case study in the power of collaboration between engineering and medicine in the development of new technologies that can dramatically improve patient care...I am deeply honored to receive the award and proud to have been at the forefront of such an important contribution to the field of vision medicine.
      In Puliafito honored with international Vision Award in Portugal
    3. We can evaluate underlying pathology and monitor disease response, retinal thickness, cystoid macular edema, vitreoretinal traction and track subretinal fluid.
      In Spectral domain OCT useful as research tool, clinical adjunct
    4. This last point may be a little counterintuitive. The patients that need the most careful macular exam, the most careful scrutiny with OCT, are the patients with relatively good vision that you're considering operating on because they actually in many ways have the most to lose by the cataract operation.
      In Surgeon suggests using OCT for preop cataract evaluation to protect patient, physician